Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

Atrial fibrillation (AF) and chronic kidney disease (CKD) often coexist as they share multiple
risk factors, including hypertension, diabetes mellitus, and coronary artery disease. Although …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Chronic kidney disease (CKD) is associated with a higher risk of atrial fibrillation (AF). The
mechanistic link between CKD and AF remains elusive. IL-1β, a main effector of NLR family …

Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions with
shared risk factors. The growing prevalence of both AF and CKD indicates that more patients …

A significant proportion of patients who suffer from atrial fibrillation (AF) and are in need of
thromboembolic protection are not treated with oral anticoagulation or discontinue this …

BACKGROUND: Recommendations for apixaban dosing on the basis of kidney function are
inconsistent between the US Food and Drug Administration and European Medicines …

The renin-angiotensin-aldosterone system regulates salt and, in part, water homeostasis,
and therefore blood pressure and fluid balance through its actions on the heart, kidneys, and …

Background At the present, apixaban is the only nonvitamin K oral anticoagulant approved
by the Food and Drug Administration for use with patients with creatinine clearance< 15 …

Background: Both atrial fibrillation and venous thromboembolism (VTE) are highly prevalent
among patients with chronic kidney disease (CKD). Until recently, warfarin was the most …